Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent Optical and Magnetic Stimulation (COMS) for Treatment of Refractory Diabetic Foot Ulcer; a Prospective Randomized, Sham-controlled, Double-blinded, Pivotal Clinical Trial

NCT05758545 is registered in ClinicalTrials.gov with Piomic Medical as lead sponsor.

NCT NCT05758545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05758545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent Optical and Magnetic Stimulation (COMS) for Treatment of Refractory Diabetic Foot Ulcer; a Prospective Randomized, Sham-controlled, Double-blinded, Pivotal Clinical Trial
Lead sponsor
Piomic Medical
Phase
Not applicable
Overall status
Recruiting
Start date
June 19, 2023
Completion date
June 19, 2027
Enrollment
450 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer